Compare ENSC & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ENSC | IZM |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 4.5M |
| IPO Year | 2017 | 2021 |
| Metric | ENSC | IZM |
|---|---|---|
| Price | $0.43 | $0.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 21.4M | 211.9K |
| Earning Date | 05-13-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.24 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,066,650.00 | N/A |
| Revenue This Year | $55.01 | N/A |
| Revenue Next Year | $1,033.97 | N/A |
| P/E Ratio | ★ N/A | $10.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.23 | $0.24 |
| 52 Week High | $2.75 | $2.73 |
| Indicator | ENSC | IZM |
|---|---|---|
| Relative Strength Index (RSI) | 65.10 | 43.39 |
| Support Level | $0.27 | $0.24 |
| Resistance Level | $0.65 | $0.30 |
| Average True Range (ATR) | 0.08 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 27.08 | 38.27 |
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
ICZOOM Group Inc. operates an e-commerce platform selling electronic components to SMEs in China across consumer electronics, IoT, automotive, and industrial control sectors. It offers two main product categories: semiconductor products, including integrated circuits and optoelectronics, and electronic equipment and tools such as electromechanical and MRO supplies. The company also provides services like customs clearance, temporary warehousing, and logistics, earning additional commission fees. The majority of its revenue comes from electronic component sales.